WOCKPHARMA — Wockhardt Share News
0.000.00%
Last trade - 00:00- IN₹317.66bn
- IN₹337.11bn
- IN₹33.73bn
Brief: India's Wockhardt Posts March-Qtr Consol Net Loss
Brief: Wockhardt Approves Raising Funds Up To 1.50 Bln Rupees
Brief: Wockhardt Says Meeting To Consider Raising Funds Has Been Postponed
Refinitiv Newscasts - Asia Insight: Indian stocks slip on profit taking, Tata, Wockhardt, COVID sniffer dogs
India's Wockhardt rises after extending COVID-19 vaccine supply deal with UK
UK extends COVID-19 vaccine supply deal with India's Wockhardt
UK Govt Announces Covid-19 Vaccination Contract Extension With Wockhardt
Brief: Wockhardt Dec-Qtr Consol Net Profit Rises
Welsh AstraZeneca vaccine facilities not disrupted by flooding, Wockhardt UK says (updated)
Welsh AstraZeneca vaccine facilities not disrupted by flooding, Wockhardt UK says
UK emergency services trying to protect AstraZeneca vaccine factory from flooding-LBC
Media: Wockhardt, IIL discuss manufacturing tie-up with vaccine major Moderna- Business Standard
AstraZeneca India unit hits over 3-month high after British vaccine approval (updated)
Factbox: Will Brexit slow Britain's COVID vaccine supplies?
UK's initial AstraZeneca shots will come from Europe, taskforce says
India's Wockhardt rises after strong results
Brief: India's Wockhardt Reports Profit in Sept-Quarter
Indian drugmaker Biological E. to make substance used in J&J's potential COVID-19 vaccine
Factbox: U.S., UK spend billions to take lead in securing coronavirus vaccines